Rezdiffra (resmetirom) — Topline data
2027
We expect results from the MAESTRO-NASH OUTCOMES trial in 2027.Source filing
MDGL biotech catalysts & pipeline
MADRIGAL PHARMACEUTICALS INC · Data as of 2026-09-08
Upcoming catalysts
Rezdiffra (resmetirom) — Topline data
2028
We expect outcomes data from this trial in 2028.Source filing